Published in J Mol Model on July 12, 2015
Specific association of human telomerase activity with immortal cells and cancer. Science (1994) 28.20
Telomeres shorten during ageing of human fibroblasts. Nature (1990) 23.97
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem (2009) 23.19
THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. Exp Cell Res (1965) 21.61
Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev (2005) 15.19
3DNA: a software package for the analysis, rebuilding and visualization of three-dimensional nucleic acid structures. Nucleic Acids Res (2003) 10.63
Sequence-specific cleavage of double helical DNA by triple helix formation. Science (1987) 9.20
Prevalence of quadruplexes in the human genome. Nucleic Acids Res (2005) 7.79
Quadruplex DNA: sequence, topology and structure. Nucleic Acids Res (2006) 6.42
Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro. Science (1988) 5.97
Telomere states and cell fates. Nature (2000) 5.71
Inhibition of telomerase by G-quartet DNA structures. Nature (1991) 5.38
Highly prevalent putative quadruplex sequence motifs in human DNA. Nucleic Acids Res (2005) 5.34
Telomere maintenance as a target for anticancer drug discovery. Nat Rev Drug Discov (2002) 3.32
Gene function correlates with potential for G4 DNA formation in the human genome. Nucleic Acids Res (2006) 3.13
DOCK 6: combining techniques to model RNA-small molecule complexes. RNA (2009) 2.75
Human POT1 disrupts telomeric G-quadruplexes allowing telomerase extension in vitro. Proc Natl Acad Sci U S A (2005) 2.63
G-quadruplex DNA: a target for drug design. Nat Med (1998) 2.38
The structure of telomeric DNA. Curr Opin Struct Biol (2003) 2.32
Hayflick, his limit, and cellular ageing. Nat Rev Mol Cell Biol (2000) 2.15
G-quadruplex DNA: a potential target for anti-cancer drug design. Trends Pharmacol Sci (2000) 1.94
Natural and pharmacological regulation of telomerase. Nucleic Acids Res (2002) 1.92
Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands. Proc Natl Acad Sci U S A (2002) 1.75
Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene (1999) 1.50
Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay. Proc Natl Acad Sci U S A (2001) 1.48
Telomere maintenance without telomerase. Oncogene (2002) 1.42
Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes. Cancer (2010) 1.41
Structural basis for binding of porphyrin to human telomeres. Biochemistry (2007) 1.37
Yeast meiosis-specific protein Hop1 binds to G4 DNA and promotes its formation. Mol Cell Biol (2000) 1.32
Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate (1993) 1.29
Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr (1995) 1.27
G-quadruplexes: targets in anticancer drug design. ChemMedChem (2008) 1.21
Telomerase inhibitors. Trends Biotechnol (2001) 1.18
The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells. Leuk Res (1994) 1.17
Differential effects of dietary phyto-oestrogens daidzein and equol on human breast cancer MCF-7 cells. Eur J Cancer (1997) 1.13
Genistein induces apoptosis in human hepatocellular carcinomas via interaction of endoplasmic reticulum stress and mitochondrial insult. Biochem Pharmacol (2006) 1.10
Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells. Mol Cancer Ther (2007) 1.08
Z-DNA, an active element in the genome. Front Biosci (2007) 1.07
A combination of indol-3-carbinol and genistein synergistically induces apoptosis in human colon cancer HT-29 cells by inhibiting Akt phosphorylation and progression of autophagy. Mol Cancer (2009) 1.06
Assessing the performance of MM/PBSA and MM/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM/GBSA and MM/PBSA rescoring. Phys Chem Chem Phys (2014) 1.01
Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells. Cancer Res (2006) 1.01
Molecular docking of intercalators and groove-binders to nucleic acids using Autodock and Surflex. J Chem Inf Model (2008) 0.98
Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells. J Nutr Biochem (2009) 0.97
Evaluation of by disubstituted acridone derivatives as telomerase inhibitors: the importance of G-quadruplex binding. Bioorg Med Chem Lett (2004) 0.95
Cruciform structures and functions. Q Rev Biophys (1996) 0.94
Equol: a comparison of the effects of the racemic compound with that of the purified S-enantiomer on the growth, invasion, and DNA integrity of breast and prostate cells in vitro. Nutr Cancer (2006) 0.93
Molecular characterization of a membrane-bound prenyltransferase specific for isoflavone from Sophora flavescens. J Biol Chem (2011) 0.90
Effect of telomere and telomerase interactive agents on human tumor and normal cell lines. Clin Cancer Res (2000) 0.89
Genistein inhibits cell growth by modulating various mitogen-activated protein kinases and AKT in cervical cancer cells. Ann N Y Acad Sci (2009) 0.87
Effect of isoflavones genistein and daidzein in the inhibition of lung metastasis in mice induced by B16F-10 melanoma cells. Nutr Cancer (1998) 0.87
Mechanistic insight into ligand binding to G-quadruplex DNA. Nucleic Acids Res (2014) 0.86
Specific inhibition of cyclic AMP-dependent protein kinase by warangalone and robustic acid. Phytochemistry (1997) 0.83
Effect of daidzein on cell growth, cell cycle, and telomerase activity of human cervical cancer in vitro. Int J Gynecol Cancer (2004) 0.79
Interaction of G-quadruplexes with nonintercalating duplex-DNA minor groove binding ligands. Bioconjug Chem (2011) 0.78
Docking studies on DNA-ligand interactions: building and application of a protocol to identify the binding mode. J Chem Inf Model (2009) 0.77
Label-free electrochemical selection of G-quadruplex-binding ligands based on structure switching. Biosens Bioelectron (2010) 0.77
Retraction. Human telomeric G-quadruplex: targeting with small molecules. FEBS J (2009) 0.77
Identification of a selective G-quadruplex DNA binder using a multistep virtual screening approach. Chem Commun (Camb) (2015) 0.76
Modeling of HIV-1 TAR RNA-ligand complexes. Med Chem (2011) 0.76
Natural isoflavones regulate the quadruplex-duplex competition in human telomeric DNA. Nucleic Acids Res (2009) 0.76